ThePharm
0403.812.681 · rovalta.com · 23/09/2026
ACTIVE
ThePharm
Financial year 2024 · closed on 31/12/2024
Net result
142 k €
+55.8% YoY
Gross margin
395,2 k €
+30.7% YoY
Equity
289 k €
-1.0% YoY
Workforce
2,7 ETP
+12.5% YoY
Overview
What does ThePharm do?
ThePharm is a Private limited company incorporated in 1968. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Antwerpen. It employs on average 2,7 ETP workers (FTE).
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0403.812.681
Incorporation
01/01/1968
Legal form
Private limited company
Registered office
Lange Stuivenbergstraat 76-78
2060 Antwerpen · FlandreSee on map
2060 Antwerpen · FlandreSee on map
Contributed capital
239 592,01 €
Latest accounts
31/12/2024
Average workforce
2,7 ETP
Activities (NACE)
Joint committees (2)
- 313
- 3130
Contacts
2 public details availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 19 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||||
| Gross margin | 395,2 k € | +30.7% | 302,4 k € | -15.9% | 359,5 k € | +17.5% | 306 k € | +15.1% | 265,9 k € | +8.2% | 245,6 k € | +6.9% | 229,9 k € | +507% | 37,9 k € | -52.5% | 79,8 k € | +70.7% | 46,8 k € | +15.4% | 40,5 k € | +478% | -10,7 k € | -1127% | -873,7 € | -112% | 7 k € | +195% | -7,3 k € | -110% | 70,5 k € | +5.5% | 66,8 k € | +20.2% | 55,6 k € | -8.5% | 60,7 k € |
| EBITDA | 269,6 k € | +42.7% | 188,9 k € | -29.2% | 266,9 k € | +37.0% | 194,8 k € | +6.1% | 183,6 k € | +4.4% | 175,9 k € | +3.0% | 170,7 k € | +389% | 34,9 k € | -55.1% | 77,9 k € | +71.7% | 45,4 k € | +15.7% | 39,2 k € | +421% | -12,2 k € | -415% | -2,4 k € | -195% | 2,5 k € | +128% | -8,9 k € | -113% | 68,7 k € | +5.5% | 65,1 k € | +22.8% | 53,1 k € | -10.0% | 58,9 k € |
| Operating result | 199,4 k € | +63.8% | 121,7 k € | -39.1% | 199,9 k € | +77.8% | 112,4 k € | +15.5% | 97,4 k € | +9.3% | 89,1 k € | +2.7% | 86,8 k € | +604% | 12,3 k € | -77.5% | 54,8 k € | +216% | 17,3 k € | -50.7% | 35,1 k € | +283% | -19,2 k € | -124% | -8,6 k € | -117% | -3,9 k € | +68.5% | -12,5 k € | -123% | 55,2 k € | +7.5% | 51,3 k € | +29.8% | 39,5 k € | -12.5% | 45,2 k € |
| Net result | 142 k € | +55.8% | 91,1 k € | -36.1% | 142,7 k € | +81.9% | 78,4 k € | +16.8% | 67,1 k € | +10.2% | 60,9 k € | +14.5% | 53,2 k € | +887% | 5,4 k € | -89.3% | 50,4 k € | -7.3% | 54,4 k € | +53.4% | 35,4 k € | +294% | -18,3 k € | -128% | -8 k € | -834% | -859,6 € | +90.5% | -9 k € | -121% | 42,4 k € | +14.9% | 36,9 k € | +36.2% | 27,1 k € | -7.1% | 29,1 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||||
| Equity | 289 k € | -1.0% | 292 k € | -30.6% | 420,9 k € | +40.6% | 299,4 k € | +6.6% | 280,9 k € | -11.9% | 318,9 k € | -6.6% | 341,6 k € | +18.4% | 288,4 k € | +217% | 91 k € | -1.4% | 92,3 k € | +143% | 37,9 k € | +1445% | 2,5 k € | -88.2% | 20,7 k € | -27.9% | 28,8 k € | -83.0% | 169,6 k € | -5.1% | 178,7 k € | +31.1% | 136,3 k € | +37.1% | 99,4 k € | +7.7% | 92,4 k € |
| Total assets | 664,8 k € | -12.3% | 757,8 k € | -2.5% | 777,1 k € | -4.2% | 811,1 k € | -5.9% | 861,5 k € | -6.3% | 919,6 k € | -3.2% | 950,5 k € | +138% | 399,6 k € | -35.0% | 615 k € | +1.6% | 605,1 k € | +145% | 247,3 k € | +18.5% | 208,6 k € | -1.6% | 212,1 k € | -5.1% | 223,4 k € | -50.0% | 447 k € | +87.5% | 238,5 k € | +14.2% | 208,8 k € | -10.4% | 232,9 k € | -0.4% | 233,9 k € |
| Cash | 152 k € | -6.1% | 161,9 k € | +117% | 74,4 k € | +7.7% | 69,1 k € | +12.8% | 61,2 k € | +71.1% | 35,8 k € | -46.2% | 66,5 k € | +314% | 16 k € | -64.0% | 44,5 k € | +152% | 17,7 k € | -32.1% | 26 k € | +60.7% | 16,2 k € | -59.5% | 40 k € | +12.5% | 35,5 k € | -73.4% | 133,4 k € | +3705% | 3,5 k € | +67.2% | 2,1 k € | -91.9% | 25,8 k € | +1.2% | 25,5 k € |
| Debts | 371 k € | -19.3% | 459,6 k € | +31.5% | 349,6 k € | -30.7% | 504,2 k € | -11.9% | 572,2 k € | -3.0% | 589,7 k € | -1.2% | 596,8 k € | +512% | 97,5 k € | -80.7% | 506,5 k € | +2.5% | 494,1 k € | +148% | 199,6 k € | -2.4% | 204,5 k € | +6.9% | 191,3 k € | -1.7% | 194,6 k € | -29.9% | 277,4 k € | +364% | 59,8 k € | -17.5% | 72,5 k € | -45.4% | 132,7 k € | -5.9% | 141 k € |
| Other | |||||||||||||||||||||||||||||||||||||
| Workforce | 2,7 ETP | +12.5% | 2,4 ETP | +4.3% | 2,3 ETP | -4.2% | 2,4 ETP | +71.4% | 1,4 ETP | +27.3% | 1,1 ETP | +83.3% | 0,6 ETP | – | – | – | – | – | – | – | – | – | – | – | – | ||||||||||||
Estimate
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2024 · 1 active · 7 ended
Active mandates
Active
Financials
Annual accounts
Full financial information
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 27/05/2025 | 22/03/2024 | 23/06/2023 | 04/07/2022 | 29/06/2021 | 13/07/2020 |
| General meeting | 14/03/2025 | 06/03/2024 | 21/06/2023 | 15/06/2022 | 16/06/2021 | 17/06/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
19 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 14/03/2025 | 27/05/2025 | Dutch | |
| Abridged model | 31/12/2023 | 06/03/2024 | 22/03/2024 | Dutch | |
| Abridged model | 31/12/2022 | 21/06/2023 | 23/06/2023 | Dutch | |
| Abridged model | 31/12/2021 | 15/06/2022 | 04/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 16/06/2021 | 29/06/2021 | Dutch | |
| Abridged model | 31/12/2019 | 17/06/2020 | 13/07/2020 | Dutch | |
| Abridged model | 31/12/2018 | 28/06/2019 | 29/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 20/06/2018 | 29/08/2018 | Dutch | |
| Abridged model | 31/03/2017 | 01/09/2017 | 31/10/2017 | Dutch | |
| Abridged model | 31/03/2016 | 02/09/2016 | 19/10/2016 | Dutch | |
| Abridged model | 31/03/2015 | 04/09/2015 | 09/09/2015 | Dutch | |
| Abridged model | 31/03/2014 | 05/09/2014 | 06/10/2014 | Dutch | |
| Abridged model | 31/03/2013 | 06/09/2013 | 30/10/2013 | Dutch | |
| Abridged model | 31/03/2012 | 07/09/2012 | 12/09/2012 | Dutch | |
| Abridged model | 31/03/2011 | 02/09/2011 | 28/09/2011 | Dutch | |
| Abridged model | 31/03/2010 | 03/09/2010 | 30/09/2010 | Dutch | |
| Abridged model | 31/03/2009 | 04/09/2009 | 21/09/2009 | Dutch | |
| Abridged model | 31/03/2008 | 26/09/2008 | 22/10/2008 | Dutch | |
| Abridged model | 31/03/2007 | 28/09/2007 | 25/10/2007 | Dutch |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2024 · 1 active · 7 ended
Active mandates
Active
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Other24/04/2025ALGEMENE VERGADERING - BOEKJAAR - DIVERSEN
- Mandates02/08/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
- Mandates28/12/2022ONTSLAGEN - BENOEMINGEN
- Mandates21/03/2018ONTSLAGEN - BENOEMINGEN
- Registered office25/01/2018MAATSCHAPPELIJKE ZETEL - KAPITAAL - AANDELEN - ALGEMENE VERGADERING - BOEKJAAR
- Restructuring24/01/2017BENAMING - KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring24/11/2016RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Registered office09/10/2013MAATSCHAPPELIJKE ZETEL
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024142 k €↑
- 2023Annual accounts 202391,1 k €↓
- 2022Annual accounts 2022142,7 k €↑
- 2021Annual accounts 202178,4 k €↑
- 2020Annual accounts 202067,1 k €↑
- 2019Annual accounts 201960,9 k €↑
- 2018Annual accounts 201853,2 k €↑
- 2017Annual accounts 20175,4 k €↓
- 2017Annual accounts 201750,4 k €↓
- 2017Name changeThePharm
- 2016Annual accounts 201654,4 k €↑
- 2015Annual accounts 201535,4 k €↑
- 2014Annual accounts 2014-18,3 k €↓
- 2013Annual accounts 2013-8 k €↓
- 2012Annual accounts 2012-859,6 €↑
- 2011Annual accounts 2011-9 k €↓
- 2010Annual accounts 201042,4 k €↑
- 2009Annual accounts 200936,9 k €↑
- 2008Annual accounts 200827,1 k €↓
- 2007Annual accounts 200729,1 k €
- 2007Name changeBRESSELEERS
- 01/01/1968IncorporationPrivate limited company